Al's Comment:

 This is the drug that used to be called Onc-201.  It finally got approved as the first drug ever approved for diffuse midline glioma!
The Musella Foundation supported the development of this drug from the start!


Posted on: 08/06/2025

Jazz Pharmaceuticals Announces U.S. FDA Approval of Modeyso™ (dordaviprone) as the First and Only Treatment for Recurrent H3 K27M-mutant Diffuse Midline Glioma

 


Click HERE to return to brain tumor news headlines.


Our privacy / cookie policy has changed.
Click HERE to read it!